152 related articles for article (PubMed ID: 8296238)
1. [The treatment of chronic myeloleukemia with recombinant alfa-2 interferon].
Strozha I; Petukhov V; Bondare D; Feldmane G; Duks A; Teilane I; Medne I; Mauritsas M; Grinberga L
Ter Arkh; 1993; 65(10):62-6. PubMed ID: 8296238
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant alpha-interferon (reaferon) in the treatment of patients with chronic myeloleukemia].
Khoroshko ND; Savchenko VG; Kholopova EI; Kotel'nikov VM; Zakharova AV; Semenova EA; Marchenko VI
Ter Arkh; 1990; 62(7):41-7. PubMed ID: 2251664
[TBL] [Abstract][Full Text] [Related]
3. [The use of interferon-alfa (reaferon) in patients with chronic myeloleukemia].
Machiulaĭtene ER; Lasunskaia EB; Nefedova IuB; Perekalina TA; Salogub GN; Poliakova LE
Ter Arkh; 1996; 68(10):44-7. PubMed ID: 9026942
[TBL] [Abstract][Full Text] [Related]
4. [Experience with the use of reaferon (alfa 2-interferon) for treating patients with chronic myeloleukemia].
Abdulkadyrov KM; Moiseev SI; Shcherbakova EG; Balashova VA; Glazanova TV; Rukavitsyn OA; Martynkevich IS; Gritsaev SV; Blinov MN
Ter Arkh; 1995; 67(6):59-63. PubMed ID: 7667786
[TBL] [Abstract][Full Text] [Related]
5. [A comparative analysis of the effect of alpha 2-interferon (reaferon) therapy on the morphofunctional state of the bone marrow in patients with chronic myeloleukemia].
Abdulkadyrov KM; Rukavitsyn OA; Moiseev SI; Rugal' VI
Gematol Transfuziol; 1993 Mar; 38(3):11-3. PubMed ID: 8020725
[TBL] [Abstract][Full Text] [Related]
6. [Interferon alfa-2b treatment of adult patients during early chronic phase of Ph1-positive chronic myeloid leukemia (initial report on a cooperative study, protocol CML-MIG-97)].
Khoroshko ND; Turkina AG; Zakharova AV; Kobzev IuN; Domracheva EV; Tikhonova LIu; Semenova EA; Zhuravlev VS; Sokolova MA; Kuznetsov SV
Ter Arkh; 1999; 71(7):42-7. PubMed ID: 10481867
[TBL] [Abstract][Full Text] [Related]
7. [A modern therapeutic strategy in Ph-positive chronic myeloleukemia].
Khoroshko ND; Turkina AG; Zhuravlev VS; Sokolova MA; Mikhaĭlova IN; Zakharova AV; Domracheva EV; Semenova EA
Ter Arkh; 1996; 68(7):22-7. PubMed ID: 8928067
[TBL] [Abstract][Full Text] [Related]
8. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
Hughes TP; Kaeda J; Branford S; Rudzki Z; Hochhaus A; Hensley ML; Gathmann I; Bolton AE; van Hoomissen IC; Goldman JM; Radich JP;
N Engl J Med; 2003 Oct; 349(15):1423-32. PubMed ID: 14534335
[TBL] [Abstract][Full Text] [Related]
9. Extramedullary blast crisis in a patient with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic remission.
O'Brien S; Witt R; Talpaz M; Kantarjian H
Cancer; 1991 Apr; 67(7):1946-9. PubMed ID: 2004308
[TBL] [Abstract][Full Text] [Related]
10. [Low doses of alpha-interferon preparations in the treatment of patients with chronic myeloleukemia].
Abdulkadyrov KM; Udal'eva VIu; Rukavitsyn OA; Bessmel'tsev SS
Ter Arkh; 2000; 72(7):22-7. PubMed ID: 10983316
[TBL] [Abstract][Full Text] [Related]
11. Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.
Freund M; von Wussow P; Knüver-Hopf J; Mohr H; Pohl U; Exeriede G; Link H; Wilke HJ; Poliwoda H
Blut; 1988 Nov; 57(5):311-5. PubMed ID: 3196882
[TBL] [Abstract][Full Text] [Related]
12. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
[TBL] [Abstract][Full Text] [Related]
14. Biotherapy of chronic myelogenous leukemia with interferon.
Ozer H
Semin Oncol; 1988 Oct; 15(5 Suppl 5):14-20. PubMed ID: 2461592
[No Abstract] [Full Text] [Related]
15. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
Nese M; de Bellis R; Urtiarte R; Di Landro J
Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047
[TBL] [Abstract][Full Text] [Related]
16. [Interferon and chronic myeloid leukemia].
Steegmann JL; Pérez Sánchez M; Fernández-Rañada JM
Sangre (Barc); 1990 Jun; 35(3):213-7. PubMed ID: 2204124
[No Abstract] [Full Text] [Related]
17. Complete cytogenetic and molecular remission in a case of lymphoid blast crisis in chronic myeloid leukemia with intensive chemotherapy and interferon alpha.
Fabbiano F; Santoro A; Di Trapani F; Marino MA; Pampinella M; Caronia F
Eur J Haematol; 1993 Aug; 51(2):122-3. PubMed ID: 8370420
[No Abstract] [Full Text] [Related]
18. Interferon induced cytogenetic improvement in CGL patients in haematological relapse post allograft.
Aitchison R; Collins P; Newland AC
Bone Marrow Transplant; 1990 Dec; 6(6):453. PubMed ID: 2097016
[No Abstract] [Full Text] [Related]
19. [Therapy of chronic myelogenous leukemia in 2004].
Hochhaus A; Berger U; Hehlmann R
Dtsch Med Wochenschr; 2004 Oct; 129(40):2122-7. PubMed ID: 15455305
[TBL] [Abstract][Full Text] [Related]
20. CML: new biologic therapies, endpoints and questions.
Martin A; Cheson BD
Oncology (Williston Park); 1987 Sep; 1(7):12-3, 16. PubMed ID: 3152809
[No Abstract] [Full Text] [Related]
[Next] [New Search]
